Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
31.86%
operating margin TTM
34.36%
revenue TTM
9.82 Billion
revenue per share TTM
38.3$
valuation ratios | |
|---|---|
| pe ratio | 28.74 |
| peg ratio | 0.06 |
| price to book ratio | 6.09 |
| price to sales ratio | 9.14 |
| enterprise value multiple | 23.08 |
| price fair value | 6.09 |
profitability ratios | |
|---|---|
| gross profit margin | 86.11% |
| operating profit margin | 34.36% |
| pretax profit margin | 38.31% |
| net profit margin | 31.86% |
| return on assets | 15.13% |
| return on equity | 22.14% |
| return on capital employed | 19.72% |
liquidity ratios | |
|---|---|
| current ratio | 2.52 |
| quick ratio | 2.16 |
| cash ratio | 1.20 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 344.94 |
| operating cycle | 405.46 |
| days of payables outstanding | 101.76 |
| cash conversion cycle | 303.71 |
| receivables turnover | 6.03 |
| payables turnover | 3.59 |
| inventory turnover | 1.06 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.06 |
| debt equity ratio | 0.09 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.08 |
| interest coverage | 230.79 |
| cash flow to debt ratio | 2.52 |
cash flow ratios | |
|---|---|
| free cash flow per share | 13.63 |
| cash per share | 24.86 |
| operating cash flow per share | 14.98 |
| free cash flow operating cash flow ratio | 0.91 |
| cash flow coverage ratios | 2.52 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 11.09 |
Frequently Asked Questions
When was the last time Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) reported earnings?
Vertex Pharmaceuticals Incorporated (VRTX) published its most recent earnings results on 05-08-2025.
What is Vertex Pharmaceuticals Incorporated's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)'s trailing twelve months ROE is 22.14%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Vertex Pharmaceuticals Incorporated (VRTX) currently has a ROA of 15.13%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did VRTX's net profit margin stand at?
VRTX reported a profit margin of 31.86% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is VRTX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.52 in the most recent quarter. The quick ratio stood at 2.16, with a Debt/Eq ratio of 0.09.